The 2014 Muscle Study Group Meeting took place at the Beaver Hollow Conference Center (Java Center, NY) – September
The meeting, titled “Economic Considerations in the Development of New Treatments for Neuromuscular Diseases” brought together members of the pharmaceutical industry, NIH and academic researchers.
Final Agenda
Abstracts
Meeting abstracts were published in Muscle and Nerve 2014;50:S1 (September 2014)
Presentations
The Muscle Study Group has received approval from the authors to publish the following presentations on our website.
Transcriptome Profiling Identifies Key Differences Between Patients with Recessive or Dominant Negative Mutations in Collagen VI Related Myopathies – Russell Butterfield
Complications of Pregnancy in Myotonic Dystrophy – Nicholas Johnson
Funding New Investigators: The Role of the CTSAs – Karl Kieburtz
Targeting Mitochondrial Free Radical Production in Aging Skeletal Muscle – David Marcinek
Outcomes: MDA-NINDS Workshop – John Porter
Cataloging FDA’s Flexibility in Subpart H and Orphan Drug Approvals – Frank Sasinowski
Patient-Reported Outcomes (PROs) in Randomized Clinical Trials (RCTs) – Ira Shoulson
MRI in Experimental Muscle Therapeutics – Tracey Willis
Sponsors
The Muscle Study Group wishes to thank the sponsors of the 2014 annual meeting: